| scholarly article | Q13442814 |
| P2093 | author name string | S Park | |
| S Lee | |||
| M Cho | |||
| H Kim | |||
| W Kim | |||
| J Youn | |||
| S Min | |||
| J Min | |||
| C Cho | |||
| P2860 | cites work | Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity | Q24306484 |
| Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor | Q24338518 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist | Q28306642 | ||
| Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity | Q29619700 | ||
| Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis | Q33562931 | ||
| Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice | Q34266204 | ||
| Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. | Q34293044 | ||
| Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis | Q34566660 | ||
| Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples | Q35348875 | ||
| Serum interleukin 12 concentration in juvenile chronic arthritis | Q35547995 | ||
| TNF alpha--a pivotal role in rheumatoid arthritis? | Q36092239 | ||
| Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts | Q36351406 | ||
| Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells | Q36362214 | ||
| Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease | Q36364080 | ||
| T helper phenotype and genetic susceptibility in experimental Lyme disease | Q36364505 | ||
| Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids | Q36365681 | ||
| Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts | Q36394980 | ||
| Heterogeneity of cytokine secretion patterns and functions of helper T cells | Q38257524 | ||
| The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials | Q40914450 | ||
| Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes | Q41020266 | ||
| Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells | Q41539687 | ||
| B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy | Q42675165 | ||
| American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis | Q47643186 | ||
| Increased release of interleukin-12p40 in MS: association with intracerebral inflammation | Q48390502 | ||
| Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis | Q57081069 | ||
| Inhibition of the human allogeneic mixed lymphocyte response by cyclosporin A: relationship with the IL-12 pathway | Q58621154 | ||
| Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis | Q60461800 | ||
| Serum interleukin-12 levels in patients with multiple sclerosis | Q61913051 | ||
| Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts | Q67569079 | ||
| Human TH1 and TH2 subsets: doubt no more | Q68316539 | ||
| Altered cytokine activity in adjuvant inhibition of autoimmune diabetes | Q70477284 | ||
| Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA) | Q71018485 | ||
| Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies | Q71339960 | ||
| Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice | Q71811775 | ||
| In vitro expression of activation markers and lymphocyte proliferation in response to interleukin 12: effect of immunosuppressive agents | Q71878928 | ||
| Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice | Q71930242 | ||
| Induction and prevention of colonic inflammation in IL-2-deficient mice | Q71968278 | ||
| Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production | Q72686394 | ||
| Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus | Q74485864 | ||
| Interleukin-12 is expressed by infiltrating macrophages and synovial lining cells in rheumatoid arthritis and osteoarthritis | Q77359149 | ||
| P433 | issue | 1 | |
| P921 | main subject | patient | Q181600 |
| rheumatoid arthritis | Q187255 | ||
| inflammation | Q101991 | ||
| P304 | page(s) | 175-181 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA). | |
| P478 | volume | 119 |
| Q40372208 | A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate |
| Q39029629 | A review on interleukins: The key manipulators in rheumatoid arthritis |
| Q46548945 | Attenuation of nociceptive pain and inflammatory disorders by total steroid and terpenoid fraction of Euphorbia tirucalli Linn root in experimental in vitro and in vivo model |
| Q93106999 | Bedside to bench: defining the immunopathogenesis of psoriatic arthritis |
| Q34700316 | Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis |
| Q34559795 | Clinical significance of cytokine determination in synovial fluid |
| Q35733792 | Cytokines in the rheumatic diseases |
| Q37316594 | Evidence that cytokines play a role in rheumatoid arthritis |
| Q39029766 | Human secreted stabilin-1-interacting chitinase-like protein aggravates the inflammation associated with rheumatoid arthritis and is a potential macrophage inflammatory regulator in rodents |
| Q51298173 | IL-12B Gene Polymorphisms and IL-12 p70 Serum Levels Among Patients with Rheumatoid Arthritis. |
| Q80473556 | Immune complex-stimulated production of interleukin-12 in peripheral blood mononuclear cells is regulated by the complement system |
| Q79277558 | Inflammatory cytokines correlated with clinical outcome of temporomandibular joint irrigation in patients with chronic closed lock |
| Q40854002 | Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza |
| Q35043799 | Inhibition of interleukin-12 production by auranofin, an anti-rheumatic gold compound, deviates CD4(+) T cells from the Th1 to the Th2 pathway |
| Q31108680 | Interleukin 12B gene polymorphisms and susceptibility to rheumatoid arthritis: a data synthesis |
| Q35882730 | Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis. |
| Q43836783 | Local interleukin-12 gene transfer promotes conversion of an acute arthritis to a chronic destructive arthritis. |
| Q58590534 | Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells |
| Q28187644 | Pathophysiological roles for IL-18 in inflammatory arthritis |
| Q40489339 | Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever |
| Q33555281 | Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging |
| Q38176803 | Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets |
| Q37125947 | Signal transducer and activation of transcription (STAT) 4beta, a shorter isoform of interleukin-12-induced STAT4, is preferentially activated by estrogen |
| Q40891825 | Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis. |
| Q43797371 | The IL-12 role in donor cell engraftment in a murine model of semiallogenic GVH disease with signs of autoimmune disease |
| Q53563550 | The clinical role of IL-23p19 in patients with rheumatoid arthritis. |
| Q51821980 | Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. |
| Q34041797 | Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis |
Search more.